SUMMARY Serum and urinary urate concentrations were studied in 44 patients with homozygous sickle cell (SS) disease, and in 27 controls with normal haemoglobin. Hyperuricaemia (> 0 39 mmol/l (6-5 mg/100 ml)) occurred in 41 % of SS patients and inversely correlated with renal urate clearance but not with indices of bone marrow turnover. Higher serum urate concentrations occurred in patients with proteinuria, probably due to associated tubular damage. Higher serum urate concentrations and lower urate clearance occurred in males compared to females.
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Hyperuricaemia is a common feature of homozygous sickle cell (SS) disease.1 2 Its clinical significance is not clear, as gout is considered to be rare in this disease.3 4 Factors contributing to hyperuricaemia in SS disease include the markedly increased red cell turnover,5 decreased renal excretion,2 6 and perhaps diminished uricolysis in the gut. This study was undertaken to determine the relative contribution of haematological factors and of renal excretion to the serum urate concentrations in a group of SS outpatients on an unrestricted diet.
Patients and methods

PATIENTS
Patients were drawn from routine attendances at the Sickle Cell Clinic of the University Hospital of the West Indies. There were 44 patients with SS disease (23 male, 21 female) with ages ranging from 9-61 yr (mean ± SD, 25 6 ± 10 7 yr). All were in the steady state-that is, without acute complications, at the time of examination but proteinuria of more than 0 1 g/24 h was present in 7 (3 male, 4 female). None was in renal failure (range of serum creatinine: 20-110 I mol/l (0-22-1-24 mg/100 ml)). Criteria for the diagnosis of SS disease, which have been reviewed elsewhere,7 included haemoglobin electrophoresis on cellulose acetate and agar gel, quantification of HbA2, and family studies where possible.
Controls were healthy West Indian medical and laboratory staff of predominantly African origin with normal haemoglobin electrophoresis (AA genotype). There were 27 controls (11 male, 16 Accepted for publication 6 January 1981 female) with ages ranging from 13-49 yr (mean ± SD, 28-9 ± 9.4 yr). No patients or controls were taking any medication at the time of the study.
METHODS
A single mid-morning urine sample and concurrent serum sample taken from each patient and control were stored at -20°C and thawed out before analysis. No dietary restrictions were imposed.
Urate concentration in serum and urine were measured colorimetrically on the Technicon AA1 autoanalyser, paired samples having a variation of 3 %. No consistent changes were observed between frozen samples and freshly analysed specimens, values differing by up to 0-02 mmol/l (0 33 mg/ 100 ml). The increased bilirubin concentration common in SS disease was shown not to interfere with the estimation of urate, at bilirubin concentrations up to 300 ,umol/l (17-5 mg/100 ml).
Creatinine in urine and serum was estimated by the alkaline picrate method on the Technicon SMA 6/60 autoanalyser by the reduction of phosphotungstic acid. There was no significant difference in Cu/Ccr (Table 2) between patients and controls. However when patients were divided in normouricaemic and hyperuricaemic groups, mean Cu/Ccr in the hyperuricaemic group (4 04) was significantly lower than in the normouricaemic group (7 32) (p < 0 02).
Serum urate concentrations correlated inversely with Cu/Ccr (r = -0-49, p < 0-01), in males (r = -0-52 p < 0-02) but not in females (r = -0-37, NS) ( Figure) .
Values of Cu/Ccr were consistently higher in females in all subgroups of SS disease (p < 0 05) and in normal controls (p < 0 02).
In SS patients with proteinuria mean Cu/Ccr was lower than in those without proteinuria but the difference did not reach statistical significance (3 93 vs 6 04, p > 0 05).
URATE EXCRETION
In SS patients, Uu/Ucr was greater than in controls (p <0001, Table 3 ). Raisedratios( > 0 5,2SDabove the mean ratio in controls) occurred in 16/44 (36%) SS patients, all but one of these were normouricaemic. In hyperuricaemic patients Uu/Ucr was lower The haematological indices are summarised in Table 4 . As expected all patients were anaemic (Hb range 5-7-10 g/dl), with raised reticulocyte counts (range 4-18%) and bilirubin concentrations (range 17-245 ptmol/l (1 0-14-3 mg/100 ml)). Haemoglobin F concentrations varied from 01 to 8-6%. These values did not differ in normouricaemic and hyperuricaemic groups, but the patients with proteinuria had a lower haemoglobin than those without proteinuria (p < 0 05). Haemoglobin was inversely correlated with Uu/Ucr ratios in normouricaemic male (r = -0-82, p < 0 001), but not in female patients. Serum urate did not correlate with reticulocyte counts, or HbF concentrations which are both related to rate of red cell turnover. There was no relation between serum urate and bilirubin concentrations.
Discussion
The occurrence of hyperuricaemia, defined as a serum urate concentration above 0 39 mmol/l (6-5 mg/100 ml), in 41 % patients is in close agreement with another study,6 and confirms that hyperuricaemia is a common feature of SS disease.' 2 Theoretically hyperuricaemia may result from increased production of uric acid, decreased excretion, or a combination of both. Studies of red cell survival and endogenous carbon monoxide production during the steady state in SS disease have suggested that the In contrast to hyperuricaemia, gout is infrequently observed in SS disease.3 4 It is possible that the prevalence of gout has been underestimated since retrospective diagnosis is difficult in a disease where self-limiting attacks of joint pain with symptom free intervals are frequent. As hyperuricaemia is common, the diagnosis will depend on joint fluid analysis for urate crystals. In a study of 56 patients with SS disease, Espinoza and coworkers did not find any case of gout during follow-up periods of 6 to 18 months. Most of our hyperuricaemic patients without proteinuria have serum urate concentrations ranging from 0 42 to 0 48 mmol/1 (7 05-8O06 mg/ 100 ml), a concentration at which only 12 % of men in the Framingham Study developed gout over a period of 12 yr.22 Long follow-up would therefore be necessary before the incidence of gouty arthritis in SS disease could be established.
In conclusion, our findings indicate that the major determinant of hyperuricaemia in SS disease is reduced renal urate clearance probably consequent upon damage to the medullary vessels and renal tubules. Urate overproduction appears to be of secondary importance but may contribute by overloading the mechanisms available for excretion. The role if any, of intestinal uricolysis in SS disease remains to be determined. 
